期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

低分子肝素非注射给药的研究概况 被引量：1

Research status of noninvasive delivery methods for low molecular weight heparin
下载PDF
导出
摘要 目的综述低分子肝素非注射给药的最新研究进展。方法依据近年来国内外相关文献对低分子肝素给药途径与新剂型等方面进行分析、整理和归纳。结果非注射途径给药方式,尤其是口服给药方式是研究的热点。结论低分子肝素的非注射给药开发前景广阔。
作者 王娟 翟光喜 于爱华
机构地区 山东大学药学院
出处 《中国生化药物杂志》 CAS CSCD 2006年第5期310-312,共3页 Chinese Journal of Biochemical Pharmaceutics
关键词 低分子肝素 剂型 非注射给药
分类号 R977.6 [医药卫生—药品] R943 [医药卫生—药剂学]
  • 相关文献

参考文献24

  • 1Schmitz T,Leitner V M,Bernkop-Schnürch A.Oral heparin delivery:design and in vivo evaluation of a stomach-targeted mucoadhesive delivery system[J].J Pharmac Sci,2005,94(5):966-973.
  • 2Mori S,Matsuura A,Rama Prasad Y V,et al.Studies on the intestinal absorption of low molecular weight heparin using saturated fatty acids and their derivatives as an absorption enhancer in rats[J].Biol Pharm Bull,2004,27(3):418-421.
  • 3Prasad Y V,Minamimoto T,Yoshikawa Y,et al.In situ intestinal absorption studies on low molecular weight heparin in rats using labrasol as absorption enhancer[J].Int J Pharmac,2004,271(1-2):225-232.
  • 4Thanou M,Verhoef J C,Junginger H E.Oral drug absorption enhancement by chitosan and its derivatives[J].Adv Drug Deliver Rev,2001,(52):117-126.
  • 5Yang T,Arnold J J,Ahsan F.Tetradecylmaltoside (TDM) enhances in vitro and in vivo intestinal absorption of enoxaparin,a low molecular weight hepari n[J].J Drug Target,2005,13(1):29-38.
  • 6Kast C E,Guggi D,Langoth N,et al.Development and in vivo evaluation of an oral delivery system for low molecular weight heparin based on thiolated polycarbophil[J].Pharm Res,2003,20(6):931-936.
  • 7Lee Y,Nam J H,Shin H C,et al.Conjugation of low-molecular-weight heparin and deoxycholic acid for the development of a new oral anticoagulant agent[J].Circulation,2001,104(25):3116-3120.
  • 8Hoffart V,Ubrich N,Simonin C,et al.Low molecular weight Heparin-loaded polymeric nanoparticles:formulation,characterization,and release characteristics[J].Drug Dev Ind Pharmac,2002,28(9):1091-1099.
  • 9Hoffart V,Ubrich N,Lamprecht A,et al.Microencapsulation of low molecular weight heparin into polymeric particlesdesigned with biodegradable and nonbiodegradable polycationic polymers[J].Drug delivery,2003,10 (1):1-7.
  • 10Kima S K,Lee E H,Lee Y K,et al.Tricapryl in microemulsion for oral delivery of low molecular weight heparin conjugates[J].J Control Release,2005,105:32-42.

二级参考文献20

共引文献19

同被引文献2

  • 1Smith SC Jr,Feldman TE,Hirshfeld JW Jr,et al.ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention;a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention).Circulation,2006,113;e166-e286.
  • 2Silber S,Albertsson P,Aviles FF,et al.Guidelines for Percutaneous coronary intervention.Eur Heart J,2005,26(8);804-847.

引证文献1

二级引证文献1

中国生化药物杂志
2006年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部